Factors related to early castration resistance in metastatic prostate cancer. Results from the National Prostate Cancer Registry in Spain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors related to early castration resistance in metastatic prostate cancer. Results from the National Prostate Cancer Registry in Spain

Published:2019-12 Issue:10 Volume:43 Page:562-567
ISSN:2173-5786
Container-title:Actas Urológicas Españolas (English Edition)
language:en
Short-container-title:Actas Urológicas Españolas (English Edition)

Author:

Lloret-Durá M.A.,Panach-Navarrete J.,Martínez-Jabaloyas J.M.,Valls-González L.,Cózar-Olmo J.M.,Miñana-López B.,Gómez-Veiga F.,Rodríguez-Antolín A.

Publisher

Elsevier BV

Reference20 articles.

1. SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017);Cassinello;Clin Transl Oncol,2017

2. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer;Cornford;Eur Urol,2017

3. Irrefutable evidence for the use of docetaxel in newly diagnosed metastatic prostate cancer: results from the STAMPEDE and CHAARTED trials;Van Soest,2015

4. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer | NEJM [Internet]. New England Journal of Medicine. 2017 [cited 12 May 2018]. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1704174.

5. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;New Eng J Med,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP